These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8129560)

  • 1. Molecular species occurring in naturally induced interferon alpha.
    Kruzel ML; Seman G; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):179-83. PubMed ID: 8129560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrodissociation of high molecular weight complexes of interferon alpha during recycling isoelectric focusing.
    Kruzel ML; Rodkey LS; Georgiades JA
    J Biol Regul Homeost Agents; 1989; 3(2):79-83. PubMed ID: 2816493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of glycosilation in the susceptibility of "acid labile" interferon alpha to acid treatment.
    Capobianchi MR; Mattana P; Gentile M; Conciatori GC; Ankel H; Dianzani F
    J Biol Regul Homeost Agents; 1991; 5(4):147-53. PubMed ID: 1803862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel concept in the purification of human leukocyte interferon.
    Kruzel ML; Georgiades JA
    J Biol Regul Homeost Agents; 1989; 3(1):20-4. PubMed ID: 2544082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation.
    Payvandi F; Amrute S; Fitzgerald-Bocarsly P
    J Immunol; 1998 Jun; 160(12):5861-8. PubMed ID: 9637497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IFN-alpha-inducing capacity of Sendai Virus in human leukocytes is independent from the hemagglutinating and hemolytic activities and from the viral proteins of the Sendai Virus preparations.
    Mattana P; Scapol L; Silvestri S; Viscomi GC
    J Biol Regul Homeost Agents; 1999; 13(4):201-6. PubMed ID: 10703943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient interferon-alpha response of newborns in comparison to adults.
    Neustock P; Kruse A; Bock S; St Pierre B; Kirchner H
    Lymphokine Cytokine Res; 1993 Apr; 12(2):109-14. PubMed ID: 8391859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interferons-alpha and -beta, tumor necrosis factor-alpha and transcription factors, IRF-1 and IRF-2, in leukocytes induced during interferon production.
    Lopez-Ocejo O; Herrera A; Herrera L; De la Fuente J
    Biol Res; 1995; 28(4):283-90. PubMed ID: 9251759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human interferon alpha species and receptors.
    Pestka S
    Biopolymers; 2000; 55(4):254-87. PubMed ID: 11169919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA; Lingwood CA
    J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human interferon-alpha species and hybrid proteins.
    Pestka S
    Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-4-S9-17. PubMed ID: 9208870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors.
    Palmer P; Tovey MG; Raschilas F; Brassart L; Meritet JF; Porcher R; Lebon P
    Eur Cytokine Netw; 2007 Jun; 18(2):108-14. PubMed ID: 17594944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of interleukin-10 on human leukocyte interferon-alpha production by Sendai virus.
    Zhao XX; Liao MJ; Rashidbaigi A
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):11-6. PubMed ID: 9557212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
    Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
    Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to equine interferon-alpha (IFN-alpha): new tools to neutralize IFN-activity and to detect secreted IFN-alpha.
    Wagner B; Hillegas JM; Flaminio MJ; Wattrang E
    Vet Immunol Immunopathol; 2008 Oct; 125(3-4):315-25. PubMed ID: 18586327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic activities of natural and synthetic type I interferons.
    Pfeffer LM
    Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
    Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
    J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectors of killer activity induced by interferon-alpha and gamma in peripheral blood mononuclear cells.
    Sakaguchi M; Kubota S; Nishikido M; Taniguchi K; Inuzuka S; Saito Y; Kanetake H; Koga S
    Int J Mol Med; 2002 Sep; 10(3):317-20. PubMed ID: 12165807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cells.
    Yamamoto-Yamaguchi Y; Okabe-Kado J; Kasukabe T; Honma Y
    Anticancer Res; 2003; 23(3B):2537-47. PubMed ID: 12894538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.